Agilent - Breakthroughs in Immunotherapy- 2019 - 3

Welcome

I

mmunotherapy is changing the landscape of cancer treatment, but
most of the available tools are adapted and not purpose-built for this
cell-centric workflow. A safe, potent, and persistent immune cell product
depends on developers mustering the full repertoire of immune cell function;
activation, proliferation, cell fate, cytotoxic killing, immunomodulation, and
memory. All of which must be accomplished in the ever-changing,
suppressive, and toxic tumor microenvironment.
Agilent is dedicated to supporting these next-generation cell therapies,
providing key technologies to enable high-efficiency gene editing and
assessment of real-time cell function, phenotype, fitness and fate. Used together, this tool
bench provides the capability to measure and control immune cell function, thus enabling
translational researchers and developers to achieve the necessary level of therapeutic potency
and safety.
This e-book provides the latest recommendations from various leaders in immunotherapy
research and their insights into exciting new developments. Their inspiration has guided and
helped us compile these articles that showcase new analysis tools for scientists developing
innovative cell-based solutions.
David Ferrick, Ph.D., senior director of the
Cell Analysis Division at Agilent Technologies

A SPONSORED PUBLICATION FROM



http://www.genengnews.com

Agilent - Breakthroughs in Immunotherapy- 2019

Table of Contents for the Digital Edition of Agilent - Breakthroughs in Immunotherapy- 2019

Contents
Agilent - Breakthroughs in Immunotherapy- 2019 - 1
Agilent - Breakthroughs in Immunotherapy- 2019 - 2
Agilent - Breakthroughs in Immunotherapy- 2019 - 3
Agilent - Breakthroughs in Immunotherapy- 2019 - Contents
Agilent - Breakthroughs in Immunotherapy- 2019 - 5
Agilent - Breakthroughs in Immunotherapy- 2019 - 6
Agilent - Breakthroughs in Immunotherapy- 2019 - 7
Agilent - Breakthroughs in Immunotherapy- 2019 - 8
Agilent - Breakthroughs in Immunotherapy- 2019 - 9
Agilent - Breakthroughs in Immunotherapy- 2019 - 10
Agilent - Breakthroughs in Immunotherapy- 2019 - 11
Agilent - Breakthroughs in Immunotherapy- 2019 - 12
Agilent - Breakthroughs in Immunotherapy- 2019 - 13
Agilent - Breakthroughs in Immunotherapy- 2019 - 14
Agilent - Breakthroughs in Immunotherapy- 2019 - 15
Agilent - Breakthroughs in Immunotherapy- 2019 - 16
Agilent - Breakthroughs in Immunotherapy- 2019 - 17
Agilent - Breakthroughs in Immunotherapy- 2019 - 18
Agilent - Breakthroughs in Immunotherapy- 2019 - 19
Agilent - Breakthroughs in Immunotherapy- 2019 - 20
Agilent - Breakthroughs in Immunotherapy- 2019 - 21
Agilent - Breakthroughs in Immunotherapy- 2019 - 22
Agilent - Breakthroughs in Immunotherapy- 2019 - 23
Agilent - Breakthroughs in Immunotherapy- 2019 - 24
Agilent - Breakthroughs in Immunotherapy- 2019 - 25
Agilent - Breakthroughs in Immunotherapy- 2019 - 26
Agilent - Breakthroughs in Immunotherapy- 2019 - 27
Agilent - Breakthroughs in Immunotherapy- 2019 - 28
Agilent - Breakthroughs in Immunotherapy- 2019 - 29
Agilent - Breakthroughs in Immunotherapy- 2019 - 30
Agilent - Breakthroughs in Immunotherapy- 2019 - 31
Agilent - Breakthroughs in Immunotherapy- 2019 - 32
Agilent - Breakthroughs in Immunotherapy- 2019 - 33
Agilent - Breakthroughs in Immunotherapy- 2019 - 34
Agilent - Breakthroughs in Immunotherapy- 2019 - 35
Agilent - Breakthroughs in Immunotherapy- 2019 - 36
Agilent - Breakthroughs in Immunotherapy- 2019 - 37
Agilent - Breakthroughs in Immunotherapy- 2019 - 38
Agilent - Breakthroughs in Immunotherapy- 2019 - 39
https://www.nxtbookmedia.com